Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs).

Is It Time to Add Universal CMV Screening for Newborns?

BOSTON — The time for universal congenital cytomegalovirus (cCMV) screening may well be here, researchers said. In a study of nearly 24,000 newborns across six

October 14, 2023

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire. Last week, the Food and Drug Administration

October 11, 2024

Drug shortages reached a record high as 2023 drew to a close

The number of ongoing and active drug shortages in the U.S. stood at 323 during the fourth quarter of last year — the highest figure

April 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.